West Pharmaceutical Services Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1.5% | +1.5% | +2.6% | +0.2% | +4.4% | +0.0% | +7.6% | -3.6% | -2.2% | +5.0% | +5.9% | -2.9% | +4.2% | +3.4% | +7.2% | +4.1% | +5.8% | +15.6% | +7.9% | -2.4% | +3.2% | -1.3% | +7.2% | -11.0% | +3.2% | +1.1% | +5.3% | -0.9% | -2.1% | -5.0% | +1.0% | +6.4% | +0.2% | -6.7% | +9.7% | +5.0% | +0.1% | +5.0% | +3.2% | – | |
| – | +1.4% | -2.1% | +7.5% | +0.1% | +5.1% | -2.0% | +8.7% | -2.9% | -2.3% | +2.6% | +5.1% | -1.1% | +2.9% | +2.1% | +2.5% | +7.5% | +3.2% | +8.0% | +2.4% | +2.6% | +4.4% | -0.3% | +3.9% | -7.3% | +6.2% | +0.1% | +3.8% | -0.9% | -1.1% | +2.4% | +1.4% | +2.3% | -1.6% | -1.8% | +5.9% | +3.6% | -1.9% | +9.5% | -1.0% | – | |
| – | +1.7% | +9.0% | -6.6% | +0.4% | +2.9% | +4.6% | +5.4% | -5.0% | -1.9% | +10.2% | +7.5% | -6.5% | +7.0% | +6.0% | +16.5% | -1.9% | +10.8% | +28.9% | +16.0% | -8.8% | +1.4% | -2.7% | +12.3% | -16.4% | -1.5% | +2.7% | +8.0% | -0.9% | -3.6% | -17.1% | +0.0% | +14.7% | +3.5% | -15.2% | +17.4% | +7.4% | +3.5% | -2.5% | +11.1% | – | |
| – | +6.7% | +7.3% | -2.9% | -9.0% | +6.6% | -1.0% | +12.5% | -6.5% | -3.0% | +0.0% | -2.0% | -3.1% | +9.7% | +4.9% | +0.9% | +15.7% | +3.2% | -5.4% | +13.1% | -5.1% | +4.6% | +6.6% | -1.4% | -5.6% | +16.9% | +7.5% | -3.5% | -0.6% | +12.2% | -4.3% | -0.6% | -11.4% | +19.4% | -11.9% | +17.2% | -10.5% | +27.5% | -27.5% | +24.7% | – | |
| – | +4.5% | +1.1% | -1.6% | +1.5% | -4.2% | +16.0% | +2.5% | -7.3% | -8.0% | +14.9% | +2.5% | -7.8% | +6.5% | +4.1% | +8.2% | -1.9% | +102.1% | -45.4% | +10.2% | -0.9% | +6.6% | -18.1% | -2.0% | -13.3% | +70.8% | -15.1% | -10.6% | +0.7% | +1.1% | -3.7% | -4.3% | +0.6% | +2.2% | +3.2% | +9.0% | +7.1% | +3.7% | -6.6% | +18.2% | – | |
| – | +1.8% | +5.1% | -1.8% | +13.0% | -14.0% | +24.4% | +2.1% | -7.5% | -43.6% | +70.8% | +1.9% | -7.3% | +6.9% | +4.2% | +4.6% | -2.4% | +5.9% | +3.6% | +15.3% | -1.4% | +6.4% | -12.3% | -2.1% | -16.7% | +27.2% | +1.5% | +1.7% | -6.2% | +10.2% | -3.8% | -3.6% | -3.1% | +6.6% | +0.5% | +10.3% | +4.2% | +22.5% | -18.7% | +25.8% | – | |
| – | +1.5% | +14.1% | -12.3% | -16.3% | +33.0% | -18.3% | +11.2% | -0.9% | +60.8% | -21.7% | +14.0% | -5.7% | +7.1% | +7.8% | +28.0% | -1.4% | +14.6% | +47.4% | +16.4% | -12.6% | -1.4% | +3.3% | +19.9% | -16.2% | -13.8% | +3.5% | +11.8% | +2.0% | -10.7% | -25.6% | +3.0% | +28.3% | +1.7% | -24.7% | +23.2% | +9.8% | -9.8% | +13.1% | +1.1% | – | |
| – | -50.0% | +100.0% | +11.1% | -45.0% | +90.9% | -14.3% | +22.2% | -13.6% | +15.8% | +0.0% | -13.6% | +5.3% | -5.0% | +5.3% | -5.0% | +5.3% | +35.0% | -33.3% | +0.0% | -5.6% | +82.4% | -32.3% | -14.3% | +16.7% | -23.8% | +37.5% | +18.2% | +11.5% | -62.1% | +36.4% | +0.0% | -53.3% | +14.3% | -50.0% | -75.0% | +0.0% | +5,200.0% | -64.2% | +36.8% | – | |
| – | +7.9% | +11.8% | -29.9% | +55.9% | -4.9% | -9.2% | +10.7% | +1.8% | +5.9% | +6.9% | +14.1% | -17.6% | +19.6% | +11.1% | +20.0% | -3.5% | +14.9% | +51.4% | +22.1% | -14.6% | -3.0% | +7.2% | +19.3% | -39.4% | -6.5% | +24.0% | +16.1% | +0.4% | -10.1% | -23.2% | +1.1% | +26.4% | -0.9% | -31.8% | +42.2% | +7.4% | -4.9% | +8.9% | +0.0% | – | |
| – | +11.8% | -86.3% | +31.8% | +382.8% | +341.4% | -79.8% | -52.0% | +33.3% | +86.3% | +8.1% | -3.7% | -29.7% | +51.4% | -9.1% | +6.7% | +31.9% | -3.3% | +40.7% | +12.5% | -62.8% | +185.0% | -38.0% | +108.5% | -53.8% | +41.7% | -18.3% | +47.5% | -15.5% | +17.3% | -52.5% | +33.5% | +47.9% | +13.6% | -34.5% | +25.3% | +12.6% | -2.1% | +34.2% | -28.0% | – | |
| – | +4.0% | +55.8% | -36.3% | +31.4% | -104.9% | – | +28.7% | -1.6% | -5.8% | +6.5% | +19.3% | -14.8% | +13.5% | +16.3% | +22.7% | -9.8% | +19.6% | +53.7% | +23.9% | -6.2% | -15.9% | +17.7% | +8.5% | -36.0% | -14.6% | +35.9% | +10.8% | +4.0% | -15.1% | -15.8% | -3.5% | +22.2% | -4.3% | -31.0% | +46.8% | +6.2% | -5.6% | +5.1% | +11.0% | – | |
| – | +4.2% | +9.7% | -21.7% | +34.4% | -3.0% | -5.1% | +7.2% | +1.6% | +5.7% | +3.5% | +10.5% | -14.5% | +14.5% | +8.4% | +13.6% | -1.5% | +14.2% | +40.7% | +17.4% | -11.9% | +3.1% | -0.1% | +18.3% | -35.1% | -4.0% | +18.8% | +15.6% | +1.8% | -9.0% | -19.8% | +2.8% | +21.5% | +0.1% | -26.6% | +31.5% | +9.4% | -3.5% | +4.3% | +3.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.